RNAZ
USDTransCode Therapeutics Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$9.910
Máximo
$10.450
Mínimo
$9.500
Volumen
0.01M
Fundamentos de la Empresa
Capitalización de Mercado
8.7M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
0.14M
Bolsa
NCM
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
TransCode Therapeutics presents preliminary data from its completed Phase 1a study with TTX-MC138 in metastatic disease at ESMO
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) announces completion of Phase 1a clinical trial with TTX-MC138, an investigational inhibitor of...
TransCode Therapeutics (RNAZ) announces the acquisition of Polynoma and a $25 Million strategic financing by a subsidiary of CK Life Sciences to form a first-in-class unique immuno-oncology and metastatic prevention oncology company
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) ("TransCode or the "Company") announced today that it entered into a definitive agreement to acquire...
Acciones Relacionadas
CUBB
Customers Bancorp Inc 5.375% Subordinated Notes Due 2034
KEQU
Kewaunee Scientific Corporation
CACC
Credit Acceptance Corporation
OTTR
Otter Tail Corporation
MGRE
Affiliated Managers Group Inc. 6.750% Junior Subordinated Notes due 2064
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.